Global Natural Biomaterials Market was valued at US$ 75.07 billion in 2021, according to the Global Natural Biomaterials Market Report, by Product Type (Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin/chitosan, Others), by Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Neurological Disorders/Central Nervous Systems, Tissue Engineering, Ophthalmology, and Others), and by Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa), published by Coherent Market Insights
Global natural biomaterials market was valued at US$ 75.07 Billion in 2021. Natural biomaterials market is expected to register a CAGR of 14.45% over the forecast period (2022–2030), to reach US$ 244.91 Million by 2030.
The natural biomaterials market growth is driven by increasing demand for orthobiologics, escalating usage of natural biomaterials in spine surgeries along with growing orthopedic and cardiovascular surgeries. Furthermore, rising investments in biomaterials field, tremendous growth for plastic surgery, and wound healing applications are expected to boost market growth in the near future. Biomaterials are used for replacing or repairing body tissues and organs Biomaterials are categorized into two main groups: synthetic and natural biomaterials. Synthetic biomaterials are classified as ceramics, metals, biodegradable, and non-biodegradable polymers. Synthetic biomaterials are applied in clinical treatment such as dacron, metal hip, plastic intraocular lens, and other applications. Synthetic biomaterials have few drawbacks including their structure and its composition not being similar to native tissues or organs. Their biocompatibility and ability to induce tissue remodeling is low in comparison with natural biomaterials. Therefore, natural biomaterials play a vital role in replacing tissues and organs and have been attracting scientist’s interest across the globe. Naturally derived biomaterial are derived from biologicals sources such as harvested animal tissues or human donor. Natural Biomaterials has applications in bone regeneration, cardiovascular regeneration, nerve regeneration, and hepatic regeneration.
The COVID-19 pandemic had a significant influence on general hospital treatment globally as well as on the operation of the global economy. The market for orthopedic implants was muted in the short term since many hospitals and clinics remain shuttered due to lockdowns, lowering the need for biomaterials. Consequently, the need for biomaterials has been declined as non-emergent therapies is delayed. The pandemic also significantly influenced many important European nations, including the U.S., Japan, and China. Sales of these products have decreased due to the pandemic and worldwide lockdowns because most of these nations are major producers of biomaterials. The market for biomaterials was consequently slightly harmed.